Literature DB >> 2106368

Livingston-Wheeler therapy.

.   

Abstract

Livingston-Wheeler's cancer treatment is based on the belief that cancer is caused by a bacterium she has named Progenitor cryptocides. Careful research using modern techniques, however, has shown that there is no such organism and that Livingston-Wheeler has apparently mistaken several different types of bacteria, both rare and common, for a unique microbe. In spite of diligent research to isolate a cancer-causing microorganism, none has been found. Similarly, Livingston-Wheeler's autologous vaccine cannot be considered an effective treatment for cancer. While many oncologists have expressed the hope that someday a vaccine will be developed against cancer, the cause(s) of cancer must be determined before research can be directed toward developing a vaccine. The rationale for other facets of the Livingston-Wheeler cancer therapy is similarly faulty. No evidence supports her contention that cancer results from a defective immune system, that a whole-foods diet restores immune system deficiencies, that abscisic acid slows tumor growth, or that cancer is transmitted to humans by chickens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106368     DOI: 10.3322/canjclin.40.2.103

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  3 in total

Review 1.  Redrawing therapeutic boundaries: microbiota and cancer.

Authors:  Jonathan Sholl; Gregory D Sepich-Poore; Rob Knight; Thomas Pradeu
Journal:  Trends Cancer       Date:  2021-11-26

Review 2.  Intratumor microbiome in cancer progression: current developments, challenges and future trends.

Authors:  Jinyan Liu; Yi Zhang
Journal:  Biomark Res       Date:  2022-05-31

Review 3.  The microbiome and human cancer.

Authors:  Gregory D Sepich-Poore; Laurence Zitvogel; Ravid Straussman; Jeff Hasty; Jennifer A Wargo; Rob Knight
Journal:  Science       Date:  2021-03-26       Impact factor: 47.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.